Join Us for a Free CME Lunch Satellite Symposium
Sunday, October 8, 2023
12 to 12:15 p.m. (HST): Registration and Lunch
12:15 to 1:15 p.m. (HST): Educational Program
Hawaiʻi Convention Center - Room 312
The discovery of the mechanisms of type 2 (T2) inflammation in asthma gave rise to biologic therapies that have dramatically expanded treatment options for patients with moderate-to-severe eosinophilic or allergic asthma. Newly approved and emerging therapies that target the epithelial alarmins represent an important opportunity to improve outcomes for patients with a broad range of asthma phenotypes. In this CME satellite symposium, presented by National Jewish Health, expert faculty will provide insights into the new paradigm of treatments and how to manage the complexity of severe asthma treatment.
This program will focus on the role of epithelial alarmins in the inflammatory cascade of asthma, and connecting clinical characteristics to patients' biomarkers for treatment. Topics include: current challenges in severe asthma management; the pathophysiology of severe asthma; targets for current and emerging treatments; and selecting treatments based on patient phenotypes.
Learning Objectives:
At the completion of the activity, attendees will be able to:
1. Explain the mechanisms of action of biologic therapies for severe asthma and key features of severe asthma that are targets for treatment.
2. Describe the role of the respiratory epithelium in asthma and the relationship to T2 and non-T2 airway inflammation.
3. Evaluate the emerging data for new and emerging therapies that target the epithelial alarmins.
4. Connect clinical characteristics and phenotypes to the targeted treatment.
Target Audience:
Pulmonologists who treat patients with asthma.
Program Faculty:
 |
Rohit K. Katial, MD, FAAAAI, FACAAI, FACP
Professor of Medicine
Associate Vice President of Education
Director, Center for Clinical Immunology
Irene J. and Dr. Abraham E. Goldminz, Chair in Immunology and Respiratory Medicine
National Jewish Health | Denver, Colorado |
| |
|
 |
Eileen Wang, MD, MPH
Associate Professor
Division of Allergy & Clinical Immunology
Department of Medicine
National Jewish Health
Denver, Colorado |
| |
|
 |
Michael E. Wechsler, MD, MMSc
Director of The Cohen Family Asthma Institute and Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, Colorado |
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@njhealth.org.
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support:
Supported by an Educational Grant from AstraZeneca Pharmaceuticals.
This symposium is not supported, endorsed, or accredited by the American College of Chest Physicians.
Registration Information:
If interested in attending, please RSVP below. Please arrive early to allow time for registration and lunch.